Prof Dr. Inga Zerr

Staff Status
unigoe
 

1-85 of 85
 
The bibliographical data in your publication list are complete
You can correct existing data in the blue highlighted fields.To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
The bibliographic data in your publication list may be incomplete. You can
  • add any missing data in the fields marked in red or
  • correct existing data in the blue highlighted fields.
To do this, please click on the coloured field. It is not possible to delete data here.
Fields that are not marked in colour (e. g. the authors) can be edited using the input form. To do so, click on the in front of the respective publication.
Check/Uncheck all
  • 2021 Journal Article | Original Work
    ​ Neural cell-surface and intracellular autoantibodies in patients with cognitive impairment from a memory clinic cohort
    Hansen, N.; Malchow, B.; Zerr, I. ; Stöcker, W.; Wiltfang, J.   & Timäus, C. (2021) 
    Journal of Neural Transmission128(3) pp. 357-369.​
    Details  DOI 
  • 2021 Journal Article
    ​ Cerebrospinal Fluid Iron‐Ferritin Ratio as a Potential Progression Marker for Parkinson's Disease
    Maass, F. ; Michalke, B.; Willkommen, D.; Canaslan, S.; Schmitz, M. ; Bähr, M.   & Zerr, I.  et al. (2021) 
    Movement Disorders,.​
    Details  DOI 
  • 2021 Journal Article | Original Work | 
    ​ Neurodegenerative Proteinopathies in the Proteoform Spectrum—Tools and Challenges
    Noor, A.; Zafar, S.   & Zerr, I.  (2021) 
    International Journal of Molecular Sciences22(3) pp. 1085.​
    Details  DOI 
  • 2020 Journal Article
    ​ Sporadic Creutzfeldt-Jakob Disease among Physicians, Germany, 1993–2018
    Hermann, P. ; Treig, J.; Unkel, S. ; Goebel, S. ; Bunck, T. ; Jünemann, M. & Friede, T.  et al. (2020) 
    Emerging Infectious Diseases26(8).​
    Details  DOI 
  • 2020 Journal Article
    ​ Elemental fingerprint: Reassessment of a cerebrospinal fluid biomarker for Parkinson's disease
    Maass, F. ; Michalke, B.; Willkommen, D.; Leha, A. ; Schulte, C.; Tönges, L.   & Mollenhauer, B.  et al. (2020) 
    Neurobiology of Disease134 pp. 104677.​
    Details  DOI 
  • 2020 Journal Article
    ​ A novel V272D presenilin mutation associated with logopenia, disorientation, and apraxia in an autosomal-dominant Alzheimer's disease family
    Mengel, D.; Liu, L.; Yamamoto, R.; Zülow, S.; Deuschl, C.; Hermann, D. M. & Zerr, I.  et al. (2020) 
    Neurobiology of Aging85 pp. 154.e5-154.e7.​
    Details  DOI 
  • 2020 Journal Article
    ​ Age and the association between apolipoprotein E genotype and Alzheimer disease: A cerebrospinal fluid biomarker–based case–control study
    Saddiki, H.; Fayosse, A.; Cognat, E.; Sabia, S.; Engelborghs, S.; Wallon, D. & Alexopoulos, P. et al. (2020) 
    PLoS Medicine17(8) pp. e1003289.​
    Details  DOI 
  • 2020 Journal Article
    ​ Genetic prion disease: opportunities for early therapeutic intervention with rigorous pre-symptomatic trials
    Hermann, P. ; Koch, J. C.   & Zerr, I.  (2020) 
    Expert Opinion on Investigational Drugs29(12) pp. 1313-1316.​
    Details  DOI 
  • 2020 Journal Article
    ​ Unveiling the Physical and Functional Niches of FAM26F by Analyzing Its Subcellular Localization and Novel Interacting Partners
    Malik, U.; Zafar, S. ; Younas, N. ; Zerr, I.   & Javed, A. (2020) 
    ACS Omega5(35) pp. 22008-22020.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Effect of the micro-environment on α-synuclein conversion and implication in seeded conversion assays
    Candelise, N. ; Schmitz, M. ; Thüne, K. ; Cramm, M. ; Rabano, A.; Zafar, S.   & Stoops, E. et al. (2020) 
    Translational Neurodegeneration9(1).​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
    Maass, F. ; Rikker, S.; Dambeck, V. ; Warth, C.; Tatenhorst, L. ; Csoti, I. & Schmitz, M.  et al. (2020) 
    Scientific Reports10(1).​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
    Hansen, N.; Hirschel, S.; Stöcker, W.; Manig, A.; Falk, H. S.; Ernst, M. & Vukovich, R. et al. (2020) 
    Frontiers in Psychiatry11.​
    Details  DOI 
  • 2020 Journal Article
    ​ RNAs in Brain and Heart Diseases
    Beis, D.; Zerr, I. ; Martelli, F.; Doehner, W. & Devaux, Y. (2020) 
    International Journal of Molecular Sciences21(10) pp. 3717.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ The role of cellular prion protein in lipid metabolism in the liver
    Arora, A. S. ; Zafar, S. ; Latif, U.; Llorens, F. ; Mihm, S.; Kumar, P. & Tahir, W.  et al. (2020) 
    Prion14(1) pp. 95-108.​
    Details  DOI 
  • 2020 Journal Article
    ​ SFPQ and Tau: critical factors contributing to rapid progression of Alzheimer’s disease
    Younas, N. ; Zafar, S. ; Shafiq, M. ; Noor, A.; Siegert, A.; Arora, A. S.   & Galkin, A. et al. (2020) 
    Acta Neuropathologica140(3) pp. 317-339.​
    Details  DOI 
  • 2020 Journal Article
    ​ Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease
    Podlesniy, P.; Llorens, F. ; Puigròs, M.; Serra, N.; Sepúlveda-Falla, D.; Schmidt, C.   & Hermann, P.  et al. (2020) 
    International Journal of Molecular Sciences21(17) pp. 6298.​
    Details  DOI 
  • 2020 Journal Article
    ​ Selenium speciation analysis in the cerebrospinal fluid of patients with Parkinson’s disease
    Maass, F. ; Michalke, B.; Willkommen, D.; Schulte, C.; Tönges, L. ; Boerger, M.   & Zerr, I.  et al. (2020) 
    Journal of Trace Elements in Medicine and Biology57 pp. 126412.​
    Details  DOI 
  • 2020 Journal Article
    ​ Increased C-X-C Motif Chemokine Ligand 12 Levels in Cerebrospinal Fluid as a Candidate Biomarker in Sporadic Amyotrophic Lateral Sclerosis
    Andrés-Benito, P.; Povedano, M.; Domínguez, R.; Marco, C.; Colomina, M. J.; López-Pérez, Ó. & Santana, I. et al. (2020) 
    International Journal of Molecular Sciences21(22) pp. 8680.​
    Details  DOI 
  • 2020 Journal Article
    ​ Chromogranin A Analysis in the Differential Diagnosis Across Lewy Body Disorders
    Gmitterova, K.; Varges, D. ; Schmitz, M. ; Zafar, S. ; Maass, F. ; Lingor, P.   & Zerr, I.  (2020) 
    Journal of Alzheimer's Disease73(4) pp. 1355-1361.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Cerebrospinal fluid lipocalin 2 as a novel biomarker for the differential diagnosis of vascular dementia
    Llorens, F. ; Hermann, P. ; Villar-Piqué, A. ; Diaz-Lucena, D.; Nägga, K.; Hansson, O. & Santana, I. et al. (2020) 
    Nature Communications11(1).​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Diagnostic Accuracy of Prion Disease Biomarkers in Iatrogenic Creutzfeldt-Jakob Disease
    Llorens, F. ; Villar-Piqué, A. ; Hermann, P. ; Schmitz, M. ; Calero, O.; Stehmann, C. & Sarros, S. et al. (2020) 
    Biomolecules10(2) pp. 290.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Optimization of the Real-Time Quaking-Induced Conversion Assay for Prion Disease Diagnosis
    Zerr, I. ; Cramm, M. ; da Silva Correia, S. M.; Zafar, S. ; Villar-Piqué, A. ; Llorens, F.   & Schmitz, M.  (2020) 
    Frontiers in Bioengineering and Biotechnology8.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Disease-Specific Changes in Reelin Protein and mRNA in Neurodegenerative Diseases
    Lidón, L.; Urrea, L.; Llorens, F. ; Gil, V.; Alvarez, I.; Diez-Fairen, M. & Aguilar, M. et al. (2020) 
    Cells9(5) pp. 1252.​
    Details  DOI 
  • 2020 Journal Article | 
    ​ Corrigendum: Figural Memory Impairment in Conjunction With Neuropsychiatric Symptoms in IgLON5 Antibody-Associated Autoimmune Encephalitis
    Hansen, N.; Hirschel, S.; Stöcker, W.; Manig, A.; Falk, H. S.; Ernst, M. & Vukovich, R. et al. (2020) 
    Frontiers in Psychiatry11.​
    Details  DOI 
  • 2019 Journal Article
    ​ The cellular prion protein and its derived fragments in human prion diseases and their role as potential biomarkers
    Thüne, K. ; Schmitz, M. ; Villar-Piqué, A. ; Altmeppen, H. C.; Schlomm, M.; Zafar, S.   & Glatzel, M. et al. (2019) 
    Expert review of molecular diagnostics19(11) pp. 1007-1018.​
    Details  DOI 
  • 2019 Journal Article | 
    ​ Increased expression of heme-binding protein 1 early in Alzheimer's disease is linked to neurotoxicity
    Yagensky, O.; Kohansal-Nodehi, M.; Gunaseelan, S.; Rabe, T.; Zafar, S. ; Zerr, I.   & Härtig, W. et al. (2019) 
    eLife8.​
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ The novel seizure quality index for the antidepressant outcome prediction in electroconvulsive therapy: association with biomarkers in the cerebrospinal fluid
    Kranaster, L.; Hoyer, C.; Mindt, S.; Neumaier, M.; Müller, N.; Zill, P. & Schwarz, M. J. et al. (2019) 
    European Archives of Psychiatry and Clinical Neuroscience270(7) pp. 911-919.​
    Details  DOI 
  • 2019 Journal Article
    ​ Domain-specific Quantification of Prion Protein in Cerebrospinal Fluid by Targeted Mass Spectrometry
    Minikel, E. V.; Kuhn, E.; Cocco, A. R.; Vallabh, S. M.; Hartigan, C. R.; Reidenbach, A. G. & Safar, J. G. et al. (2019) 
    Molecular & Cellular Proteomics18(12) pp. 2388-2400.​
    Details  DOI 
  • 2019 Journal Article
    ​ Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency
    Schmitz, M. ; Candelise, N. ; Kanata, E.; Llorens, F. ; Thüne, K. ; Villar-Piqué, A.   & da Silva Correia, S. M. et al. (2019) 
    Molecular Neurobiology57(4) pp. 1863-1874.​
    Details  DOI 
  • 2019 Journal Article | 
    ​ Tau-protein concentrations are not elevated in cerebrospinal fluid of patients with progressive multifocal leukoencephalopathy
    Möhn, N.; Luo, Y.; Skripuletz, T.; Schwenkenbecher, P.; Zerr, I. ; Lange, P.   & Stangel, M. (2019) 
    Fluids and Barriers of the CNS16(1).​
    Details  DOI 
  • 2019 Journal Article
    ​ Cadmium induces GAPDH- and- MDH mediated delayed cell aging and dysfunction in Candida tropicalis 3Aer
    Khan, Z.; Nisar, M. A.; Muzammil, S.; Zafar, S. ; Zerr, I.   & Rehman, A. (2019) 
    Environmental Monitoring and Assessment191(8).​
    Details  DOI 
  • 2019 Journal Article | 
    ​ Plasma YKL-40 in the spectrum of neurodegenerative dementia
    Villar-Piqué, A. ; Schmitz, M. ; Hermann, P. ; Goebel, S. ; Bunck, T. ; Varges, D.   & Ferrer, I. et al. (2019) 
    Journal of Neuroinflammation16(1) art. 145.​
    Details  DOI  PMID  PMC 
  • 2019 Journal Article
    ​ Age at onset in genetic prion disease and the design of preventive clinical trials
    Minikel, E. V.; Vallabh, S. M.; Orseth, M. C.; Brandel, J.-P.; Haïk, S.; Laplanche, J.-L. & Zerr, I.  et al. (2019) 
    Neurology93(2) pp. e125-e134.​
    Details  DOI 
  • 2019 Journal Article
    ​ Prion protein quantification in human cerebrospinal fluid as a tool for prion disease drug development
    Vallabh, S. M.; Nobuhara, C. K.; Llorens, F. ; Zerr, I. ; Parchi, P.; Capellari, S. & Kuhn, E. et al. (2019) 
    Proceedings of the National Academy of Sciences116(16) pp. 7793-7798.​
    Details  DOI 
  • 2019 Journal Article | 
    ​ Evaluation of Human Cerebrospinal Fluid Malate Dehydrogenase 1 as a Marker in Genetic Prion Disease Patients
    Zerr, I. ; Villar-Piqué, A. ; Schmitz, V. E.; Poleggi, A.; Pocchiari, M.; Sánchez-Valle, R. & Calero, M. et al. (2019) 
    Biomolecules9(12) pp. 800.​
    Details  DOI 
  • 2018 Journal Article
    ​ Diagnostic challenges in rapidly progressive dementia
    Zerr, I.   & Hermann, P.  (2018) 
    Expert Review of Neurotherapeutics18(10) pp. 761-772.​
    Details  DOI 
  • 2018 Journal Article
    ​ Cerebrospinal fluid and blood biomarkers for neurodegenerative dementias: An update of the Consensus of the Task Force on Biological Markers in Psychiatry of the World Federation of Societies of Biological Psychiatry
    Lewczuk, P. ; Riederer, P.; O’Bryant, S. E.; Verbeek, M. M.; Dubois, B.; Visser, P. J. & Jellinger, K. A. et al. (2018) 
    The World Journal of Biological Psychiatry19(4) pp. 244-328.​
    Details  DOI 
  • 2018 Journal Article
    ​ Molecular and Clinical Aspects of Protein Aggregation Assays in Neurodegenerative Diseases
    Villar-Piqué, A. ; Schmitz, M. ; Candelise, N. ; Ventura, S.; Llorens, F.   & Zerr, I.  (2018) 
    Molecular Neurobiology55(9) pp. 7588-7605.​
    Details  DOI 
  • 2018 Journal Article
    ​ Cerebrospinal Fluid Total and Phosphorylated α-Synuclein in Patients with Creutzfeldt–Jakob Disease and Synucleinopathy
    Schmitz, M. ; Villar-Piqué, A. ; Llorens, F. ; Gmitterová, K.; Hermann, P. ; Varges, D.   & Zafar, S.  et al. (2018) 
    Molecular Neurobiology56(5) pp. 3476-3483.​
    Details  DOI 
  • 2018 Journal Article | 
    ​ Regional and subtype-dependent miRNA signatures in sporadic Creutzfeldt-Jakob disease are accompanied by alterations in miRNA silencing machinery and biogenesis
    Llorens, F. ; Thüne, K. ; Martí, E.; Kanata, E.; Dafou, D.; Díaz-Lucena, D. & Vivancos, A. et al. (2018) 
    PLOS Pathogens14(1) art. e1006802.​
    Details  DOI 
  • 2018 Journal Article
    ​ Cerebrospinal fluid markers analysis in the differential diagnosis of dementia with Lewy bodies and Parkinson’s disease dementia
    Gmitterová, K.; Gawinecka, J. ; Llorens, F. ; Varges, D. ; Valkovič, P. & Zerr, I.  (2018) 
    European Archives of Psychiatry and Clinical Neuroscience270(4) pp. 461-470.​
    Details  DOI 
  • 2018 Journal Article | 
    ​ Validation of α-Synuclein as a CSF Biomarker for Sporadic Creutzfeldt-Jakob Disease
    Llorens, F. ; Kruse, N. ; Karch, A. ; Schmitz, M.; Zafar, S. ; Gotzmann, N.   & Sun, T. et al. (2018) 
    Molecular Neurobiology55(3) pp. 2249-2257.​
    Details  DOI 
  • 2018 Journal Article
    ​ DNA versus RNA oxidation in Parkinson’s disease: Which is more important?
    Gmitterová, K.; Gawinecka, J. ; Heinemann, U. ; Valkovič, P. & Zerr, I.  (2018) 
    Neuroscience Letters662 pp. 22-28.​
    Details  DOI 
  • 2018 Journal Article | 
    ​ Animal TSEs and public health: What remains of past lessons?
    Zafar, S. ; Shafiq, M. ; Andréoletti, O. & Zerr, I.  (2018) 
    PLoS Pathogens14(2) art. e1006759.​
    Details  DOI 
  • 2018 Journal Article
    ​ Validation and utilization of amended diagnostic criteria in Creutzfeldt-Jakob disease surveillance
    Hermann, P. ; Laux, M.; Glatzel, M.; Matschke, J.; Knipper, T. ; Goebel, S.   & Treig, J. et al. (2018) 
    Neurology91(4) pp. e331-e338.​
    Details  DOI 
  • 2018 Journal Article | 
    ​ Extending the functional characteristics of naturally occurring autoantibodies against β-Amyloid, Prion Protein and α-Synuclein
    Albus, A.; Gold, M.; Bach, J.-P.; Burg-Roderfeld, M.; Jördens, M.; Kirchhein, Y. & Kronimus, Y. et al. (2018) 
    PLoS One13(8) pp. e0202954.​
    Details  DOI 
  • 2018 Journal Article
    ​ Elemental fingerprint as a cerebrospinal fluid biomarker for the diagnosis of Parkinson's disease
    Maass, F. ; Michalke, B.; Leha, A. ; Boerger, M. ; Zerr, I. ; Koch, J.-C.   & Tönges, L.  et al. (2018) 
    Journal of Neurochemistry145(4) pp. 342-351.​
    Details  DOI 
  • 2018 Journal Article
    ​ Biomarkers for Antidepressant Efficacy of Electroconvulsive Therapy: An Exploratory Cerebrospinal Fluid Study
    Kranaster, L.; Hoyer, C.; Aksay, S.; Bumb, J.; Müller, N.; Zill, P. & Schwarz, M. et al. (2018) 
    Neuropsychobiology77(1) pp. 13-22.​
    Details  DOI 
  • 2017 Journal Article
    ​ Evaluation of α-synuclein as a novel cerebrospinal fluid biomarker in different forms of prion diseases
    Llorens, F. ; Kruse, N. ; Schmitz, M. ; Gotzmann, N. ; Golanska, E.; Thüne, K.   & Zejneli, O. et al. (2017) 
    Alzheimer's & Dementia: The Journal of the Alzheimer's Association13(6) pp. 710-719.​
    Details  DOI  PMID  PMC 
  • 2017 Journal Article | 
    ​ Altered Ca2+ homeostasis induces Calpain-Cathepsin axis activation in sporadic Creutzfeldt-Jakob disease
    Llorens, F. ; Fischer, A. ; Thüne, K. ; Sikorska, B.; Schmitz, M.; Tahir, W.   & Fernández-Borges, N. et al. (2017) 
    Acta Neuropathologica Communication5(35) pp. 1-20.​
    Details  DOI  PMID  PMC 
  • 2017 Journal Article
    ​ Biosorption behavior and proteomic analysis of Escherichia coli P4 under cadmium stress
    Khan, Z.; Rehman, A.; Nisar, M. A.; Zafar, S.   & Zerr, I.  (2017) 
    Chemosphere174 pp. 136-147.​
    Details  DOI 
  • 2017 Journal Article
    ​ Effect of Metformin on Adult Hippocampal Neurogenesis: Comparison with Donepezil and Links to Cognition
    Ahmed, S.; Mahmood, Z.; Javed, A.; Hashmi, S. N.; Zerr, I. ; Zafar, S.   & Zahid, S. (2017) 
    Journal of Molecular Neuroscience62(1) pp. 88-98.​
    Details  DOI 
  • 2017 Journal Article
    ​ Cytoskeleton-Associated Risk Modifiers Involved in Early and Rapid Progression of Sporadic Creutzfeldt-Jakob Disease
    Zafar, S. ; Younas, N. ; Sheikh, N.; Tahir, W. ; Shafiq, M. ; Schmitz, M.   & Ferrer, I. et al. (2017) 
    Molecular Neurobiology,.​
    Details  DOI 
  • 2017 Journal Article
    ​ Fatal Familial Insomnia: Clinical Aspects and Molecular Alterations
    Llorens, F. ; Zarranz, J.-J.; Fischer, A. ; Zerr, I.   & Ferrer, I. (2017) 
    Current Neurology and Neuroscience Reports17(4).​
    Details  DOI 
  • 2017 Journal Article | 
    ​ Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
    Llorens, F. ; Schmitz, M.; Knipper, T. ; Schmidt, C. ; Lange, P. ; Fischer, A.   & Hermann, P.  et al. (2017) 
    Frontiers in aging neuroscience9 art. 289.​
    Details  DOI  PMID  PMC 
  • 2017 Journal Article
    ​ Prion Protein Interactome: Identifying Novel Targets in Slowly and Rapidly Progressive Forms of Alzheimer’s Disease
    Zafar, S. ; Shafiq, M. ; Younas, N. ; Schmitz, M. ; Ferrer, I. & Zerr, I.  (2017) 
    Journal of Alzheimer's Disease59(1) pp. 265-275.​
    Details  DOI 
  • 2017 Journal Article
    ​ Molecular basis of Cd+2 stress response in Candida tropicalis
    Khan, Z.; Rehman, A.; Nisar, M. A.; Zafar, S. ; Hussain, S. Z.; Zerr, I.   & Hussain, I. et al. (2017) 
    Applied Microbiology and Biotechnology101(20) pp. 7715-7728.​
    Details  DOI 
  • 2017 Journal Article
    ​ Neuropsychological Symptoms in Sporadic Creutzfeldt-Jakob Disease Patients in Germany
    Krasnianski, A. ; Bohling, G. T.; Heinemann, U. ; Varges, D. ; Meissner, B. ; Schulz-Schaeffer, W. J.   & Reif, A. et al. (2017) 
    Journal of Alzheimer's Disease59(1) pp. 329-337.​
    Details  DOI 
  • 2017 Journal Article
    ​ α-synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B
    Ferreira, D. G ; Temido-Ferreira, M.; Vicente Miranda, H.; Batalha, V. L; Coelho, J. E; Szegö, É. M   & Marques-Morgado, I. et al. (2017) 
    Nature Neuroscience20(11) pp. 1569-1579.​
    Details  DOI 
  • 2016 Journal Article
    ​ Neuropsychiatrische Erkrankungen und Demenzen: ein interdisziplinärer Ansatz
    Zerr, I. ; Bandelow, B. ; Wedekind, D. ; Schneider, A. ; Radenbach, K. ; Wiltfang, J.   & Bähr, M.  (2016) 
    Aktuelle Neurologie43(06) pp. 369-371.​
    Details  DOI 
  • 2016 Journal Article
    ​ Fatal familial insomnia: mitochondrial and protein synthesis machinery decline in the mediodorsal thalamus
    Frau-Méndez, M. A.; Fernández-Vega, I.; Ansoleaga, B.; Blanco Tech, R.; Carmona Tech, M.; Antonio del Rio, J. & Zerr, I.  et al. (2016) 
    Brain Pathology27(1) pp. 95-106.​
    Details  DOI 
  • 2016 Journal Article
    ​ Molecular Alterations in the Cerebellum of Sporadic Creutzfeldt–Jakob Disease Subtypes with DJ-1 as a Key Regulator of Oxidative Stress
    Tahir, W. ; Zafar, S. ; Llorens, F. ; Arora, A. S. ; Thüne, K. ; Schmitz, M.   & Gotzmann, N.  et al. (2016) 
    Molecular Neurobiology55(1) pp. 517-537.​
    Details  DOI 
  • 2016 Journal Article
    ​ Reelin Expression in Creutzfeldt-Jakob Disease and Experimental Models of Transmissible Spongiform Encephalopathies
    Mata, A.; Urrea, L.; Vilches, S.; Llorens, F. ; Thüne, K. ; Espinosa, J.-C. & Andréoletti, O. et al. (2016) 
    Molecular Neurobiology54(8) pp. 6412-6425.​
    Details  DOI 
  • 2016 Journal Article
    ​ Hereditary Human Prion Diseases: an Update
    Schmitz, M. ; Dittmar, K.; Llorens, F. ; Gelpi, E.; Ferrer, I.; Schulz-Schaeffer, W. J.   & Zerr, I.  (2016) 
    Molecular Neurobiology54(6) pp. 4138-4149.​
    Details  DOI 
  • 2016 Journal Article
    ​ Is there a role of Tau in Huntington's disease?
    Zerr, I.   & Bähr, M.  (2016) 
    Journal of Neurochemistry139(1) pp. 9-10.​
    Details  DOI  PMID  PMC  WoS 
  • 2016 Journal Article
    ​ Stratification by Genetic and Demographic Characteristics Improves Diagnostic Accuracy of Cerebrospinal Fluid Biomarkers in Rapidly Progressive Dementia
    Karch, A. ; Llorens, F. ; Schmitz, M. ; Arora, A. S. ; Zafar, S. ; Lange, P.   & Schmidt, C.  et al. (2016) 
    Journal of Alzheimer's Disease54(4) pp. 1385-1393.​
    Details  DOI 
  • 2016 Journal Article
    ​ The real-time quaking-induced conversion assay for detection of human prion disease and study of other protein misfolding diseases
    Schmitz, M. ; Cramm, M. ; Llorens, F. ; Müller-Cramm, D.; Collins, S.; Atarashi, R. & Satoh, K. et al. (2016) 
    Nature Protocols11(11) pp. 2233-2242.​
    Details  DOI 
  • 2015 Journal Article
    ​ Subtype and regional regulation of prion biomarkers in sporadic Creutzfeldt-Jakob disease
    Llorens, F.; Zafar, S. ; Ansoleaga, B.; Shafiq, M.; Blanco, R.; Carmona, M. & Grau-Rivera, O. et al. (2015) 
    Neuropathology and Applied Neurobiology41(5) pp. 631-645.​
    Details  DOI  PMID  PMC  WoS 
  • 2015 Journal Article
    ​ Functional MRI activation in response to panic-specific, non-panic aversive, and neutral pictures in patients with panic disorder and healthy controls
    Engel, K. R. ; Obst, K. ; Bandelow, B. ; Dechent, P. ; Gruber, O. ; Zerr, I.   & Ulrich, K.  et al. (2015) 
    European Archives of Psychiatry and Clinical Neuroscience266(6) pp. 557-566.​
    Details  DOI 
  • 2014 Journal Article | 
    ​ Impact of the Cellular Prion Protein on Amyloid-beta and 3PO-Tau Processing
    Schmitz, M.; Wulf, K.; Signore, S. C. ; Schulz-Schaeffer, W. J. ; Kermer, P. ; Baehr, M.   & Wouters, F. S.  et al. (2014) 
    Journal of Alzheimer's Disease38(3) pp. 551-565.​
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article
    ​ Doxycycline in Creutzfeldt-Jakob disease: a phase 2, randomised, double-blind, placebo-controlled trial
    Haik, S.; Marcon, G.; Mallet, A.; Tettamanti, M.; Welaratne, A.; Giaccone, G. & Azimi, S. et al. (2014) 
    The Lancet Neurology13(2) pp. 150-158.​
    Details  DOI  PMID  PMC  WoS 
  • 2014 Journal Article
    ​ Loss of Prion Protein Leads to Age-Dependent Behavioral Abnormalities and Changes in Cytoskeletal Protein Expression
    Schmitz, M.; Greis, C.; Ottis, P.; Silva, C. J.; Schulz-Schaeffer, W. J. ; Wrede, A. & Koppe, K. et al. (2014) 
    Molecular Neurobiology50(3) pp. 923-936.​
    Details  DOI  PMID  PMC  WoS 
  • 2012 Journal Article
    ​ Decreased  β-amyloid1-42 in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease
    Otto, M. ; Esselmann, H. ; Schulz-Schaeffer, W. ; Neumann, M.; Schröter, A. ; Ratzka, P.   & Cepek, L.  et al. (2012) 
    Neurology54(5) pp. 1099-1102.​
    Details  DOI 
  • 2011 Journal Article
    ​ Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study
    Otto, M. ; Wiltfang, J. ; Schütz, E. ; Zerr, I. ; Otto, A.; Pfahlberg, A.   & Gefeller, O.  et al. (2011) 
    BMJ316(7131) pp. 577-582.​
    Details  DOI 
  • 2010 Journal Article
    ​ TGF-beta 1 enhances neurite outgrowth via regulation of proteasome function and EFABP
    Knöferle, J. ; Ramljak, S. ; Koch, J. C. ; Tönges, L. ; Asif, A. R. ; Michel, U.   & Wouters, F. S.  et al. (2010) 
    Neurobiology of Disease38(3) pp. 395-404.​
    Details  DOI  PMID  PMC  WoS 
  • 2010 Journal Article
    ​ Pulvinar Sign in Wernicke's Encephalopathy
    Schmidt, C. D.; Plickert, S.; Summers, D. K. & Zerr, I.  (2010) 
    CNS Spectrums15(4) pp. 215-218.​
    Details  PMID  PMC  WoS 
  • 2008 Journal Article
    ​ Overexpression of cellular prion protein alters postischemic Erk1/2 phosphorylation but not Akt phosphorylation and protects against focal cerebral ischemia
    Weise, J.; Doeppner, T. R. ; Müller, T.; Wrede, A.; Schulz-Schaeffer, W. J. ; Zerr, I.   & Witte, O. W. et al. (2008) 
    Restorative neurology and neuroscience26(1) pp. 57-64.​
    Details  PMID  PMC  WoS 
  • 2006 Journal Article
    ​ Deletion of cellular prion protein results in reduced Akt activation, enhanced postischemic caspase-3 activation, and exacerbation of ischemic brain injury
    Weise, J.; Sandau, R.; Schwarting, S.; Crome, O.; Wrede, A.; Schulz-Schaeffer, W.   & Zerr, I.  et al. (2006) 
    Stroke37(5) pp. 1296-1300.​
    Details  DOI  PMID  PMC  WoS 
  • 2005 Journal Article
    ​ Genetic prion disease: the EUROCJD experience
    Kovács, G. G.; Puopolo, M.; Ladogana, A.; Pocchiari, M.; Budka, H.; Duijn, C. van & Collins, S. J. et al. (2005) 
    Human Genetics (Berlin)118(2) pp. 166-174.​
    Details  DOI  PMID  PMC  WoS 
  • 2004 Journal Article
    ​ Upregulation of cellular prion protein (PrPc) after focal cerebral ischemia and influence of lesion severity
    Weise, J.; Crome, O.; Sandau, R.; Schulz-Schaeffer, W. ; Baehr, M.   & Zerr, I.  (2004) 
    Neuroscience Letters372(1-2) pp. 146-150.​
    Details  DOI  PMID  PMC  WoS 
  • 2000 Journal Article
    ​ Creutzfeldt-Jakob disease and oxidative stress
    Bleich, S. ; Kropp, S. ; Degner, D. ; Zerr, I. ; Pilz, J. ; Gleiter, C. H.   & Otto, M.  et al. (2000) 
    Acta Neurologica Scandinavica101(5) pp. 332-334.​
    Details  DOI  PMID  PMC 
  • 1999 Journal Article
    ​ Laborchemische Verfahren in der Differentialdiagnose der Creutzfeldt-Jakob-Krankheit
    Otto, M. ; Zerr, I. ; Wiltfang, J. ; Weber, T.; Kretzschmar, H. ; Poser, S.   & Felgenhauer, K.  (1999) 
    Deutsches Ärzteblatt33.​
    Details 
  • 1999 Journal Article
    ​ Isoform Pattern of 14-3-3 Proteins in the Cerebrospinal Fluid of Patients with Creutzfeldt-Jakob Disease
    Wiltfang, J. ; Otto, M. ; Baxter, H. C.; Bodemer, M. ; Steinacker, P. ; Bahn, E.   & Zerr, I.  et al. (1999) 
    Journal of Neurochemistry73(6) pp. 2485-2490.​
    Details  DOI  PMID  PMC 
  • 1998 Journal Article
    ​ Authors reply; Diagnosis of Creutzfeldt-Jakob disease by measurement of S100 protein in serum: prospective case-control study
    Otto, M. ; Wiltfang, J. ; Schütz, E. ; Zerr, I. ; Otto, A.; Pfahlberg, A.   & Gefeller, O.  et al. (1998) 
    British Medical Journal317 art. 472.​
    Details 
  • 1998 Journal Article
    ​ Detection of 14-3-3 protein in the cerebrospinal fluid supports the diagnosis of Creutzfeldt-Jakob disease
    Zerr, I. ; Bodemer, M. ; Gefeller, O. ; Otto, M. ; Poser, S. ; Wiltfang, J.   & Windl, O.  et al. (1998) 
    Annals of Neurology43(1) pp. 32-40.​
    Details  DOI 

Type

Date issued

Author

Publication Affiliation

Fulltext

Options

Citation Style

https://publications.goettingen-research-online.de URI: /cris/rp/rp01701
ID: 0000000
PREF: default TOKEN:

0

Sort

Issue Date
Title

Embed

JavaScript
Link

Export

Activate Export Mode
Deactivate Export Mode

Select some or all items from the publications list, then choose an export format below.